Understanding Your Hereditary Cancer Risk Is the First Step Toward Protecting Your Future and the Ones You Love
FOCUS Hereditary is a next-generation sequencing (NGS) based genetic test that comprehensively evaluates genetic alterations associated with hereditary diseases and cancer predisposition. Its broad gene coverage supports the assessment of hereditary cancer risk and the identification of clinically relevant genetic variants.
The test can be used not only for cancer risk assessment but also to support treatment and risk management in individuals diagnosed with cancer. Genetic findings may contribute to personal and familial risk assessment, appropriate surveillance strategies, and, when applicable, the evaluation of personalized treatment options.
Cancer Types:
Colorectal, Breast, Prostate, Pancreatic, Ovarian, Endometrial, Skin, Gastric, Kidney, Endocrine, and Lung Cancers
| Feature | Details |
|---|---|
| Cancer Type | Hereditary Cancers |
| Sample Type | Blood (EDTA Tube) |
| Method | Next-Generation Sequencing (NGS) |
| Coverage | 3,332 Genes |
| Turnaround Time | 3–4 Weeks |
* Genetic counseling is included as part of this test.
** Please contact us for information about our other hereditary testing options.
19 Mayıs Mah. Çoruh Sok. No:32/1 Fulya, 34394 Şişli / Istanbul, Turkey
Monday - Friday 09:00 - 18:00 Saturday 09:00 - 14:00